OGT to Develop Microarrays for HIV-AIDS Vaccine Research | GenomeWeb
NEW YORK (GenomeWeb News) - Oxford Gene Technology today said it will design an optimized oligonucleotide microarray for the Innate Discovery Team, part of the Center for IV-AIDS Vaccine Immunology.
 
The center will use the microarrays to study genes involved in the cellular immune response of early-stage HIV-infected patients.
 
OGT said the microarrays will be printed using its ink jet in situ synthesis platform for parallel analysis of multiple samples.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.